Clinical Trials in Illinois

Showing 4341-4360 of 19,692 trials

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

NCT05426174

This is a Phase I, first-in-human, randomized, modified double-blind, active-controlled, dose-escalation study to assess the safety and immunogenicity of up to 3 dose levels of mRNA NA vaccines, administered as a single IM injection in healthy adults aged 18 years and older. Two age groups, 18 to 64 years and ≥65 years, will be included in this study.

Influenza ImmunizationHealthy Volunteers

Sanofi Pasteur, a Sanofi Company233 participantsStarted Jun 2022

Huntsville, Alabama, United States • Phoenix, Arizona, United States • San Diego, California, United States +3 more locations

Active Not RecruitingNA40 miles

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

NCT05024695

Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.

Glaucoma

iSTAR Medical975 participantsStarted Aug 2021

Glendale, Arizona, United States • Fayetteville, Arkansas, United States • Beverly Hills, California, United States +34 more locations

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Find Trials by Condition in Illinois

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children

Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function

A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)

The Pediatric Artificial Pancreas Automated Initialization Trial